Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, United Kingdom.
Nutr Rev. 2019 Mar 1;77(3):181-196. doi: 10.1093/nutrit/nuy015.
Obesity, type 2 diabetes, and dental caries are all major public health problems in the United Kingdom and contribute substantially to healthcare costs.
A systematic review and meta-analysis was conducted to determine the effect of product reformulation measures on sugar intake and health outcomes.
Using a combination of terms, the following databases were searched-The Cochrane Library, EMBASE, MEDLINE (Ovid), and Scopus. Additionally, multiple gray literature searches were undertaken.
A total of 16 studies met the inclusion criteria. There were 4 randomized controlled trials, 6 studies that modeled reformulation in a country, 5 studies that modeled a different approach of reformulation, and 1 study was both a modelling study of a different approach to reformulation and a retrospective observational study. The studies were assessed for risk of bias and overall quality of evidence was rated using the Grades of Recommendation, Assessment, Development and Evaluation Working Group (GRADE) framework.
Results from randomized controlled trials suggest that consumption of reformulated products can reduce sugar intake and body weight. The pooled estimates were -11.18% (95% confidence interval [CI], -19.95 to -2.41; P < 0.00001) for changes in percentage of sugar intake, -91.00 g/day (95%CI, -148.72 to -33.28; P< 0.00001) for changes in sugar intake in grams per day, and -1.04 kg (95%CI, -2.16 to -0.08; P= 0.0002) for changes in body weight. However, the quality of the evidence was very low. Results from the other studies suggested that reformulation can reduce sugar intake and improve health. Much of the evidence draws on modeling studies.
This systematic review and meta-analysis suggests that product reformulation to reduce sugar content could reduce sugar intake in individuals and thus improve population health. These findings provide an important starting point for ongoing work on sugar reformulation.
肥胖、2 型糖尿病和龋齿都是英国的主要公共卫生问题,大量消耗医疗保健成本。
系统回顾和荟萃分析旨在确定产品配方改革措施对糖摄入量和健康结果的影响。
使用组合术语,在以下数据库中进行搜索- Cochrane 图书馆、EMBASE、MEDLINE(Ovid)和 Scopus。此外,还进行了多次灰色文献搜索。
共有 16 项研究符合纳入标准。其中有 4 项随机对照试验、6 项对国家配方改革进行建模的研究、5 项对不同配方改革方法进行建模的研究,以及 1 项既是不同配方改革方法的建模研究,也是回顾性观察性研究。对研究进行了偏倚风险评估,并使用推荐评估、制定和评估工作组(GRADE)框架对整体证据质量进行了评级。
随机对照试验的结果表明,消费改良产品可以减少糖摄入量和体重。汇总估计值为-11.18%(95%置信区间[CI],-19.95 至-2.41;P<0.00001),用于糖摄入量的百分比变化,-91.00g/天(95%CI,-148.72 至-33.28;P<0.00001),用于糖摄入量的克变化,-1.04kg(95%CI,-2.16 至-0.08;P=0.0002),用于体重变化。然而,证据质量非常低。其他研究的结果表明,配方改革可以减少糖摄入量并改善健康。大部分证据来自于模型研究。
本系统评价和荟萃分析表明,减少含糖量的产品配方改革可以减少个体的糖摄入量,从而改善人群健康。这些发现为正在进行的糖配方改革工作提供了重要的起点。